Vir Biotechnology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VIR and other ETFs, options, and stocks.About VIR
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes.
CEOMarianne de Backer
CEOMarianne de Backer
Employees408
Employees408
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded2016
Founded2016
Employees408
Employees408
VIR Key Statistics
Market cap696.72M
Market cap696.72M
Price-Earnings ratio-1.22
Price-Earnings ratio-1.22
Dividend yield—
Dividend yield—
Average volume1.17M
Average volume1.17M
High today$5.35
High today$5.35
Low today$5.04
Low today$5.04
Open price$5.18
Open price$5.18
Volume926.99K
Volume926.99K
52 Week high$14.45
52 Week high$14.45
52 Week low$4.32
52 Week low$4.32
Analyst ratings
78%
of 9 ratingsBuy
77.8%
Hold
22.2%
Sell
0%
People also own
Based on the portfolios of people who own VIR. This list is generated using Robinhood data, and it’s not a recommendation.